Pfizer had a gap down off their previous earnings release which has led to the formation of a somewhat symmetrical triangle pattern. We have seen the bullish breakout of this pattern earlier this month & the price has remained above while consolidating. If the stock price can remain above this line on a pullback then I would look for a fill of the gap from July around $40.